Incidence of Severe Uterine Bleeding Outcomes among Oral Anticoagulant Users and Nonusers

    Basic Details
    Date
    Wednesday, September 1, 2021
    Type
    Publication
    Description

    The risk of severe uterine bleeding (SUB) reported in oral anticoagulant (OA) clinical trials is likely underestimated due to the low representation of women of reproductive age. In a previous research letter, we reported SUB incidence in women who received OA treatment using real-world data. In this study, we examined the incidence of SUB among women presenting uterine bleeding (UB), with and without ongoing OA (warfarin or non-vitamin K oral anticoagulants) exposure, to contextualize our previous findings.

    Author(s)

    Ting-Ying Huang, Laura Hou, Abby Andersen, Audrey Gassman, David Moeny, Efe Eworuke

    Corresponding Author

    Ting-Ying Huang; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA
    Email: jane_huang@harvardpilgrim.org